Peptide therapy addresses physiological factors related to mental well-being, offering additional support alongside traditional treatments
An internal environment with less inflammation pulling everything down
The goal is to look younger, feel younger and live a longer life free of disease
Peripheral effects Via the AMY2 and AMY3 receptors Cagrilintide acts peripherally: Slowing of gastric emptying , stronger than with GLP-1 Suppression of postprandial glucagon , helps control postprandial glycemic spikes Modulation of bone remodeling (via AMY3), a neutral effect, but clinically monitored Synergy with GLP-1 (the mechanistic basis of CagriSema) The main innovation is the complementarity with the GLP-1 pathway : GLP-1 suppresses appetite via the arcuate nucleus of the hypothalamus (POMC neurons, AgRP/NPY inhibition) Amylin suppresses appetite via the area postrema (CGRP-like neurons) Two independent centers, two independent mechanisms
Bradycardia is often seen in professional athletes but also in hypothyroidism or as a side effect of medications taken
Studies using fluorescence microscopy and co-immunoprecipitation techniques have visualized this molecular displacement mechanism, confirming target engagement in senescent but not healthy cells